[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate

C38H53BrN12O4Si2 — CID 157112835

IUPAC[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate
SMILES[H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(-c3cnn(C)c3)cc2n1.[H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(Br)cc2n1
InChIInChI=1S/C21H29N7O2Si.C17H24BrN5O2Si/c1-15(22)30-21(23)28(14-29-8-9-31(3,4)5)20-7-6-18-19(26-20)10-16(11-24-18)17-12-25-27(2)13-17;1-12(19)25-17(20)23(11-24-7-8-26(2,3)4)16-6-5-14-15(22-16)9-13(18)10-21-14/h6-7,10-13,22-23H,8-9,14H2,1-5H3;5-6,9-10,19-20H,7-8,11H2,1-4H3/b22-15+,23-21-;19-12+,20-17-
InChIKeyAHAZKECAIZYBGX-KSIOYBABSA-N
MW878.00 g/mol
LogP8.56
Rot. Bonds13

About [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate

[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate (PubChem CID 157112835) has the molecular formula C38H53BrN12O4Si2 and a molecular weight of 878.00 g/mol. Its IUPAC name is [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate.

Molecular Properties

Compound Name[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate
PubChem CID157112835
Molecular FormulaC38H53BrN12O4Si2
Molecular Weight878.00 g/mol
Exact Mass876.30
IUPAC Name[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate
SMILES[H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(-c3cnn(C)c3)cc2n1.[H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(Br)cc2n1
InChIInChI=1S/C21H29N7O2Si.C17H24BrN5O2Si/c1-15(22)30-21(23)28(14-29-8-9-31(3,4)5)20-7-6-18-19(26-20)10-16(11-24-18)17-12-25-27(2)13-17;1-12(19)25-17(20)23(11-24-7-8-26(2,3)4)16-6-5-14-15(22-16)9-13(18)10-21-14/h6-7,10-13,22-23H,8-9,14H2,1-5H3;5-6,9-10,19-20H,7-8,11H2,1-4H3/b22-15+,23-21-;19-12+,20-17-
InChIKeyAHAZKECAIZYBGX-KSIOYBABSA-N
XLogP8.56
TPSA208.18 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds13
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500878.00
LogP ≤ 58.56
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate?
The IUPAC name of [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate (CID 157112835) is [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate.
What is the SMILES notation for [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate?
The canonical SMILES for [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate is [H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(-c3cnn(C)c3)cc2n1.[H]/N=C(\O/C(C)=N/[H])N(COCC[Si](C)(C)C)c1ccc2ncc(Br)cc2n1.
What is the InChIKey of [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate?
The InChIKey is AHAZKECAIZYBGX-KSIOYBABSA-N. The full InChI is InChI=1S/C21H29N7O2Si.C17H24BrN5O2Si/c1-15(22)30-21(23)28(14-29-8-9-31(3,4)5)20-7-6-18-19(26-20)10-16(11-24-18)17-12-25-27(2)13-17;1-12(19)25-17(20)23(11-24-7-8-26(2,3)4)16-6-5-14-15(22-16)9-13(18)10-21-14/h6-7,10-13,22-23H,8-9,14H2,1-5H3;5-6,9-10,19-20H,7-8,11H2,1-4H3/b22-15+,23-21-;19-12+,20-17-.
What are the key properties of [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate?
[N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate has a molecular weight of 878.00 g/mol, XLogP of 8.56, 13 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [N-(7-bromo-1,5-naphthyridin-2-yl)-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate;[N-[7-(1-methylpyrazol-4-yl)-1,5-naphthyridin-2-yl]-N-(2-trimethylsilylethoxymethyl)carbamimidoyl] ethanimidate is sourced from PubChem (CID 157112835), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).